CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals U.S.A., Inc.

1:23-cv-00152

Overview

Case Number 1:23-cv-00152
Filing Date 2023-02-10
Status Litigation filed
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Teva Pharmaceuticals U.S.A., Inc. Operating Company

Represented By

14 Attorneys Listed

Kimberlynn R. Seifert

Email: kseifert@sternekessler.com

Hadia S. Ahsan

Email: hahsan@sternekessler.com

David Y. Wang

Email: dwang@sternekessler.com

Byron L. Pickard

Email: bpickard@sternekessler.com

Brady P. Gleason

Email: bgleason@sternekessler.com

Sasha S. Rao

Email: SRao@sternekessler.com

Emily DiBenedetto

Shaw Keller LLP

Tel: +1 (302) 298-0713

DE, 1105 N Market St

William D. Rodenberg

Email: wrodenberg@sternekessler.com

William H. Milliken

Email: wmilliken@sternekessler.com

Nathan Roger Hoeschen

Shaw Keller LLP

Tel: +1 (302) 298-0709

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John C. Rozendaal

Email: jcrozendaal@sternekessler.com

Deirdre M. Wells

Email: dwells@sternekessler.com

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Plaintiff

Vanda Pharmaceuticals Inc. Operating Company

Represented By

9 Attorneys Listed

Samoneh Kadivar Schickel

Email: sschickel@mcdermottlaw.com

Mary H. Schnoor

Email: mschnoor@mcdermottlaw.com

Sarah P. Hogarth

Email: shogarth@mcdermottlaw.com

Paul W. Hughes

Email: phughes@mwe.com

Christopher M. Bruno

Email: chris@ipfdalaw.com

April E. Weisbruch

Email: aweisbruch@mwe.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Ethan Haller Townsend

McDermott Will & Schulte LLP

Tel: +1 (302) 485-3900

The Brandywine Building, 1000 N. West Street

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 19 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (19): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US11285129
Treatment of circadian rhythm disorders
Filed: 2021-07-06
Issued: 2022-03-29
Active (14.6 yrs remaining)
Expires: 2041-07-06

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

149

Dispositive

74

Granted

6

Denied

1

Pending / Review

105

Motions by Category

Motion for Preliminary Injunction / TRO 20 Motion to Transfer Venue (28 U.S.C. § 1404) 12 Procedural / Extension Motion 44 Motion to Dismiss (FRCP 12(b)(6)) 20 Motion to Strike / Sanctions 8 Claim Construction / Markman Filing 18 Motion to Dismiss 5 Motion to Compel Discovery 5 Motion for Summary Judgment (Infringement) 12 Motion for Summary Judgment (Rule 56) 5

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Infringement) Pending / Under Review
ORAL ORDER: At the conclusion of the October 1, 2026 teleconference, the Court ordered the parties to provide letters to the Court on specified topics. In addit...
Entry #394 • 2026-10-01 Document →
Motion to Dismiss Pending / Under Review
ORAL ORDER: Having reviewed the parties' joint status letter (No. 23-152, D.I. 391), IT IS HEREBY ORDERED that Teva's pending Motion to Dismiss Count I of Plain...
Entry #392 • 2026-09-30 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
MEMORANDUM OPINION re Defendants' Motion for Summary Judgment #1: Non-Infringement. (No. 23-152, D.I. 297; No. 23-153, D.I. 250). Signed by Judge Jennifer L. Ha...
Entry #387 • 2026-09-24 Document →
Motion for Summary Judgment (Infringement) Granted
ORDER re (314 in 1:23-cv-00153-JLH, 387 in 1:23-cv-00152-JLH) Memorandum Opinion: IT IS HEREBY ORDERED that the parties shall meet and confer as soon as practic...
Entry #388 • 2026-09-24 Document →
Motion for Summary Judgment (Rule 56) Denied
ORDER: IT IS HEREBY ORDERED that Defendants' Motion for Summary Judgment #2: The Asserted Patents Are Entitled to a Priority Date No Earlier Than July 6, 2021 (...
Entry #389 • 2026-09-24 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
[SEALED] SUPPLEMENTAL RESPONSE BRIEF in Opposition to 297 Defendants' Motion for Summary Judgment of Non-Infringement, by Vanda Pharmaceuticals Inc. (Attachment...
Entry #376 • 2026-07-16 Document →

Docket Entries

(613 total)
Pleading / Complaint

COMPLAINT against TEVA PHARMACEUTICALS USA, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-13921534) with JURY DEMAND, filed by VANDA PHARMACEUTICALS INC.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Certification Pursuant to L. Civ. R. 11.2)(QUINN, JUSTIN) [Transferred from New Jersey on 2/10/2023.] (Entered: 12/27/2022)

Entry #1 • 2022-12-27
1
Pleading / Complaint

COMPLAINT against TEVA PHARMACEUTICALS USA, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-13921534) with JURY DEMAND, filed by VANDA PHARMACEUTICALS INC.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Certification Pursuant to L. Civ. R. 11.2)(QUINN, JUSTIN) [Transferred from New Jersey on 2/10/2023.] (Entered: 12/27/2022)

Entry #1 • 2022-12-27
2
Pleading / Complaint

COMPLAINT against TEVA PHARMACEUTICALS USA, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-13921534) with JURY DEMAND, filed by VANDA PHARMACEUTICALS INC.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Certification Pursuant to L. Civ. R. 11.2)(QUINN, JUSTIN) [Transferred from New Jersey on 2/10/2023.] (Entered: 12/27/2022)

Entry #1 • 2022-12-27
2
Pleading / Complaint

COMPLAINT against TEVA PHARMACEUTICALS USA, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-13921534) with JURY DEMAND, filed by VANDA PHARMACEUTICALS INC.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Certification Pursuant to L. Civ. R. 11.2)(QUINN, JUSTIN) [Transferred from New Jersey on 2/10/2023.] (Entered: 12/27/2022)

Entry #1 • 2022-12-27
2

Corporate Disclosure Statement by VANDA PHARMACEUTICALS INC.. (QUINN, JUSTIN) [Transferred from New Jersey on 2/10/2023.] (Entered: 12/27/2022)

Entry #2 • 2022-12-27
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc